Mark Puder: Clinical Trials

1 trial sponsored by Mark Puder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 31Completed 1

Follow Mark Puder: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cholestasis Reversal: Efficacy of IV Fish Oil
Omegaven® - Parenteral Nutrition Associated Liver Disease, Short Bowel Syndrome
Phase 2 / Phase 3CompletedMark Puder912006-08-012024-09-19

Conditions studied

Cholestasis (1)  ·  Gastrointestinal Diseases (1)  ·  Short Bowel Syndrome (1)

Interventions

fish oil triglycerides (1)

Countries

United States (1)

Results publications

PMID 19661785, PMID 32059815, PMID 33038344, PMID 34695449